Goldman Sachs’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-50,000
Closed -$3.56M – 6755
2026
Q1
$3.56M Sell
50,000
-132,400
-73% -$10.4M ﹤0.01% 4018
2025
Q4
$15M Hold
182,400
– – ﹤0.01% 2662
2025
Q3
$13.7M Hold
182,400
– – ﹤0.01% 2650
2025
Q2
$13.5M Hold
182,400
– – ﹤0.01% 2484
2025
Q1
$14.7M Buy
182,400
+132,400
+265% +$11.4M ﹤0.01% 2322
2024
Q4
$3.91M Hold
50,000
– – ﹤0.01% 3700
2024
Q3
$4.69M Buy
+50,000
New +$4.2M ﹤0.01% 3396
2023
Q2
– Sell
-4,950
Closed -$406K – 5865
2023
Q1
$406K Buy
+4,950
New +$353K ﹤0.01% 4950

Other funds holding GEHC

Goldman Sachs's GEHC Position: Q2 2026 in Review

Goldman Sachs increased its GE HealthCare (GEHC) stake by 36% in Q2 2026, buying an estimated $77.6M and bringing the position to 4,446,565 shares worth $285M. The position accounts for 0.02% of the portfolio, ranked #615.

Goldman Sachs first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. 1,233 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Goldman Sachs held 4,446,565 shares of GE HealthCare worth $285M as of Q2 2026.
  • Goldman Sachs bought 1,180,427 GE HealthCare shares in Q2 2026, an estimated $77.6M.
  • GE HealthCare made up 0.02% of Goldman Sachs's portfolio in Q2 2026, its #615 holding.
  • Goldman Sachs first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • 1,233 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.